Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LEGNLegend Biotech Corp

Nasdaq · CIK 0001801198
Filer categoryLarge accelerated filer
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts257

Identity from submissions API

NameLegend Biotech Corp
CIK0001801198
TickersLEGN
ExchangesNasdaq
Entity typeother
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone732-850-5598
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2101 COTTONTAIL LANE
SOMERSET
NJ
08873
NJ
Mailing address
2101 COTTONTAIL LANE
SOMERSET
NJ
08873
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

389 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 xslF345X06/form4-11202026_041101.xml 0001964342-26-000006 5067
2026-11-16 4 xslF345X06/form4-11162026_041104.xml 0002088468-26-000008 6780
2026-11-10 6-K 6-K 0001801198-26-000026 001-39307 261537929 34 3494199 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002770 005-92217 261526196 34 11807
2026-11-04 6-K FORM 6-K 0001171843-26-007100 001-39307 261520297 34 61490
2026-10-15 6-K FORM 6-K 0001171843-26-006646 001-39307 261461368 34 16705
2026-10-13 6-K FORM 6-K 0001171843-26-006593 001-39307 261454606 34 15035
2026-10-07 S-8 FORM S-8 0001171843-26-006498 333-299349 261447189 33 330408 1 1
2026-10-01 4 xslF345X06/form4-10012026_081003.xml 0001796536-26-000010 5356
2026-09-29 144 xsl144X01/primary_doc.xml 0001959173-26-007138 001-39307 261422394 33 10452
2026-09-28 4 xslF345X06/form4-09282026_040912.xml 0002088468-26-000006 5382
2026-09-28 4 xslF345X06/form4-09282026_040909.xml 0001814673-26-000005 5406
2026-09-28 4 xslF345X06/form4-09282026_040908.xml 0002106809-26-000005 5368
2026-09-28 4 xslF345X06/form4-09282026_040906.xml 0002068365-26-000009 5398
2026-09-28 4 xslF345X06/form4-09282026_040904.xml 0001974687-26-000006 5379
2026-09-28 4 xslF345X06/form4-09282026_040901.xml 0001796536-26-000009 5424
2026-09-25 6-K FORM 6-K 0001171843-26-006229 001-39307 261406233 34 48215
2026-09-24 6-K FORM 6-K 0001171843-26-006215 001-39307 261404710 34 28502
2026-09-23 4 xslF345X06/form4-09232026_040904.xml 0002097065-26-000005 7036
2026-09-22 144 xsl144X01/primary_doc.xml 0001959173-26-007077 001-39307 261396657 33 4439
2026-09-22 144 xsl144X01/primary_doc.xml 0001959173-26-007076 001-39307 261396402 33 4869
2026-09-16 4 xslF345X06/form4-09162026_080948.xml 0001964342-26-000004 5349
2026-09-16 3 xslF345X06/form3-09162026_080907.xml 0001964342-26-000003 8298
2026-09-15 6-K FORM 6-K 0001171843-26-006050 001-39307 261379155 34 28289
2026-09-14 6-K FORM 6-K 0001171843-26-006027 001-39307 261375843 34 580342
2026-08-18 4 xslF345X06/form4-08182026_040805.xml 0001908421-26-000005 5370
2026-08-18 6-K FORM 6-K 0001171843-26-005623 001-39307 261290480 34 1632309
2026-08-11 6-K 6-K 0001801198-26-000022 001-39307 261260657 34 3752222 1 1
2026-08-06 6-K FORM 6-K 0001171843-26-005318 001-39307 261248852 34 13629
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002041 005-92217 261247097 34 11759
2026-08-03 3 xslF345X06/form3-08032026_090857.xml 0001908421-26-000004 11466
2026-07-27 6-K 6-K 0001193125-26-316760 001-39307 261202736 34 12587
2026-07-15 6-K FORM 6-K 0001171843-26-004649 001-39307 261175874 34 14714
2026-07-02 4 xslF345X06/form4-07022026_040712.xml 0002068365-26-000005 5130
2026-07-02 4 xslF345X06/form4-07022026_040714.xml 0001967360-26-000008 5028
2026-06-30 144 xsl144X01/primary_doc.xml 0001959173-26-004966 001-39307 261138838 33 5955
2026-06-29 4 xslF345X06/form4-06302026_010610.xml 0001967360-26-000006 5605
2026-06-26 144 xsl144X01/primary_doc.xml 0001959173-26-004918 001-39307 261128121 33 5070
2026-06-22 6-K 6-K 0001193125-26-277556 001-39307 261107375 34 324608
2026-06-18 424B5 424B5 0001193125-26-275977 333-278050 261103318 33 1115409 1 1
2026-06-17 424B5 424B5 0001193125-26-274318 333-278050 261099241 33 972969
2026-06-17 F-6EF F-6EF 0001104659-26-075190 333-296862 261099124 33 402104
2026-06-15 6-K FORM 6-K 0001171843-26-004120 001-39307 261089076 34 3712720
2026-06-02 6-K FORM 6-K 0001171843-26-003866 001-39307 261053884 34 51208
2026-06-01 6-K FORM 6-K 0001171843-26-003825 001-39307 261047792 34 51384
2026-05-21 6-K FORM 6-K 0001171843-26-003622 001-39307 261009560 34 52926
2026-05-12 6-K 6-K 0001801198-26-000014 001-39307 26965837 34 3358209 1 1
2026-04-14 6-K FORM 6-K 0001171843-26-002425 001-39307 26859162 34 13384
2026-03-27 4 xslF345X06/form4-03272026_080347.xml 0001967360-26-000004 5537
2026-03-26 144 xsl144X01/primary_doc.xml 0001959173-26-002641 001-39307 26798636 33 5070
2026-03-26 144 xsl144X01/primary_doc.xml 0001959173-26-002640 001-39307 26798550 33 4421
2026-03-18 3 xslF345X06/form3-03182026_110339.xml 0001814673-26-000003 13252
2026-03-18 3 xslF345X06/form3-03182026_110346.xml 0002114170-26-000002 10186
2026-03-18 3 xslF345X06/form3-03182026_110314.xml 0002088468-26-000003 11463
2026-03-18 3 xslF345X06/form3-03182026_100355.xml 0002068365-26-000002 12983
2026-03-18 3 xslF345X06/form3-03182026_100320.xml 0002121501-26-000002 11242
2026-03-18 3 xslF345X06/form3-03182026_100359.xml 0002106809-26-000002 13237
2026-03-18 3 xslF345X06/form3-03182026_100337.xml 0001974687-26-000002 13055
2026-03-18 3 xslF345X06/form3-03182026_100306.xml 0001845292-26-000002 10124
2026-03-18 3 xslF345X06/form3-03182026_100354.xml 0002097065-26-000002 9873
2026-03-18 3 xslF345X06/form3-03182026_100321.xml 0001796536-26-000002 12948
2026-03-18 3 xslF345X06/form3-03182026_100301.xml 0001967360-26-000003 20654
2026-03-18 3 xslF345X06/form3-03182026_100338.xml 0002114160-26-000002 11504
2026-03-10 20-F 20-F 0001801198-26-000008 001-39307 26737922 34 65260302 1 1
2026-03-10 6-K FORM 6-K 0001171843-26-001444 001-39307 26737118 34 154764
2026-02-06 6-K FORM 6-K 0001171843-26-000675 001-39307 26607474 34 12855
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000461 005-92217 26601952 34 11636
2026-01-23 6-K FORM 6-K 0001171843-26-000398 001-39307 26553356 34 13931
2026-01-21 6-K FORM 6-K 0001171843-26-000356 001-39307 26544797 34 14531
2026-01-14 6-K FORM 6-K 0001171843-26-000257 001-39307 26533280 34 6537810
2026-01-12 6-K FORM 6-K 0001171843-26-000206 001-39307 26524726 34 34999
2025-12-29 144 xsl144X01/primary_doc.xml 0001959173-25-007923 001-39307 251603029 33 5028
2025-12-29 144 xsl144X01/primary_doc.xml 0001959173-25-007919 001-39307 251602838 33 4424
2025-12-29 144 xsl144X01/primary_doc.xml 0001959173-25-007917 001-39307 251602800 33 5070
2025-12-08 6-K FORM 6-K 0001171843-25-007796 001-39307 251554633 34 52320
2025-11-17 144 xsl144X01/primary_doc.xml 0001968582-25-001078 001-39307 251492257 33 5129
2025-11-12 6-K 6-K 0001801198-25-000031 001-39307 251468630 34 3736104 1 1
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002798 005-92217 251452701 34 11674
2025-11-03 6-K FORM 6-K 0001171843-25-006904 001-39307 251443940 34 56778
2025-10-14 6-K FORM 6-K 0001171843-25-006414 001-39307 251389717 34 14516
2025-10-14 6-K FORM 6-K 0001171843-25-006413 001-39307 251389635 34 15564
2025-10-07 6-K FORM 6-K 0001171843-25-006329 001-39307 251379812 34 14395
2025-09-26 144 xsl144X01/primary_doc.xml 0001959173-25-006211 001-39307 251350880 33 4893
2025-09-24 144 xsl144X01/primary_doc.xml 0001959173-25-006179 001-39307 251335631 33 6834
2025-09-23 144 xsl144X01/primary_doc.xml 0001959173-25-006168 001-39307 251333355 33 6270
2025-09-23 144 xsl144X01/primary_doc.xml 0001959173-25-006167 001-39307 251333348 33 5028
2025-09-23 144 xsl144X01/primary_doc.xml 0001959173-25-006157 001-39307 251332106 33 5029
2025-08-18 6-K FORM 6-K 0001171843-25-005462 001-39307 251226302 34 22757
2025-08-11 6-K 6-K 0001801198-25-000026 001-39307 251200092 34 3810238 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002064 005-92217 251188388 34 11246
2025-07-23 144 xsl144X01/primary_doc.xml 0001959173-25-004712 001-39307 251143244 33 6784
2025-07-23 144 xsl144X01/primary_doc.xml 0001959173-25-004703 001-39307 251142322 33 4381
2025-07-16 6-K FORM 6-K 0001171843-25-004480 001-39307 251126153 34 14971
2025-06-30 6-K FORM 6-K 0001171843-25-004224 001-39307 251092005 34 11931
2025-06-26 144 xsl144X01/primary_doc.xml 0001959173-25-004302 001-39307 251076468 33 4890
2025-06-25 144 xsl144X01/primary_doc.xml 0001959173-25-004285 001-39307 251071573 33 6231
2025-06-24 144 xsl144X01/primary_doc.xml 0001959173-25-004278 001-39307 251069527 33 5681
2025-06-24 144 xsl144X01/primary_doc.xml 0001959173-25-004260 001-39307 251067027 33 5025
2025-06-12 6-K FORM 6-K 0001171843-25-003860 001-39307 251042605 34 37631
2025-06-06 6-K FORM 6-K 0001171843-25-003764 001-39307 251030443 34 6042985
2025-06-06 144 xsl144X01/primary_doc.xml 0001959173-25-003860 001-39307 251029411 33 4290
2025-06-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001640 005-92217 251029167 34 11619
2025-06-05 6-K FORM 6-K 0001171843-25-003703 001-39307 251025076 34 16453
2025-06-03 6-K FORM 6-K 0001171843-25-003621 001-39307 251017664 34 61151
2025-05-23 6-K FORM 6-K 0001171843-25-003412 001-39307 25978957 34 119786
2025-05-14 6-K FORM 6-K 0001171843-25-003155 001-39307 25942968 34 13205
2025-05-13 6-K 6-K 0001801198-25-000021 001-39307 25937082 34 3804785 1 1
2025-05-12 6-K 6-K 0001193125-25-117353 001-39307 25932747 34 79771
2025-05-01 144 xsl144X01/primary_doc.xml 0001959173-25-002778 001-39307 25900541 33 5023
2025-04-15 6-K FORM 6-K 0001171843-25-002203 001-39307 25837565 34 15065
2025-03-25 144 xsl144X01/primary_doc.xml 0001959173-25-002301 001-39307 25768098 33 4431
2025-03-25 144 xsl144X01/primary_doc.xml 0001959173-25-002300 001-39307 25768063 33 4471
2025-03-25 144 xsl144X01/primary_doc.xml 0001959173-25-002295 001-39307 25766629 33 4419
2025-03-13 144 xsl144X01/primary_doc.xml 0001959173-25-002006 001-39307 25734524 33 6001
2025-03-11 20-F 20-F 0001801198-25-000012 001-39307 25727508 34 36574044 1 1
2025-03-11 6-K FORM 6-K 0001171843-25-001386 001-39307 25725809 34 128941
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-25-000207 005-92217 25624066 34 7597
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000781 005-92217 25612409 34 11639
2025-01-22 6-K FORM 6-K 0001171843-25-000360 001-39307 25543891 34 13636
2025-01-14 6-K FORM 6-K 0001171843-25-000244 001-39307 25529375 34 6420989
2025-01-10 144 xsl144X01/primary_doc.xml 0001959173-25-000243 001-39307 25522555 33 4997
2024-12-26 144 xsl144X01/primary_doc.xml 0001959173-24-008832 001-39307 241577789 33 5085
2024-12-26 144 xsl144X01/primary_doc.xml 0001959173-24-008829 001-39307 241577532 33 4390
2024-12-23 6-K FORM 6-K 0001171843-24-007063 001-39307 241573525 34 8711761
2024-12-10 6-K FORM 6-K 0001171843-24-006838 001-39307 241536745 34 49074
2024-12-02 144 xsl144X01/primary_doc.xml 0001959173-24-008332 001-39307 241518591 33 5971
2024-11-14 SC 13G/A legn13gasep24.txt 0000080255-24-001457 005-92217 34 6420
2024-11-14 S-8 S-8 0001193125-24-258036 333-283217 241457460 33 324828 1 1
2024-11-12 SC 13G/A filing.txt 0000315066-24-002829 005-92217 241444837 34 8266
2024-11-12 6-K 6-K 0001801198-24-000043 001-39307 241443205 34 4119215 1 1
2024-11-05 6-K FORM 6-K 0001171843-24-006009 001-39307 241425944 34 52230
2024-10-22 6-K 6-K 0001193125-24-240752 001-39307 241384710 34 10235
2024-10-21 6-K 6-K 0001193125-24-240395 001-39307 241383416 34 29216
2024-10-15 6-K FORM 6-K 0001171843-24-005616 001-39307 241369262 34 12998
2024-09-27 6-K FORM 6-K 0001171843-24-005381 001-39307 241335419 34 51531
2024-09-25 144 xsl144X01/primary_doc.xml 0001959173-24-006681 001-39307 241323517 33 5080
2024-09-20 144 xsl144X01/primary_doc.xml 0001959173-24-006640 001-39307 241313885 33 9851
2024-09-20 144 xsl144X01/primary_doc.xml 0001959173-24-006630 001-39307 241312148 33 4821
2024-09-20 6-K 6-K 0001193125-24-222460 001-39307 241311712 34 137725
2024-09-16 UPLOAD filename1.pdf 0000000000-24-010456 001-39307 39569
2024-09-11 CORRESP filename1.htm 0001193125-24-217135 16795
2024-09-04 UPLOAD filename1.pdf 0000000000-24-010011 001-39307 45875
2024-08-27 6-K FORM 6-K 0001171843-24-004939 001-39307 241243345 34 11223
2024-08-09 6-K 6-K 0001801198-24-000038 001-39307 241190370 34 4096154 1 1
2024-08-08 6-K FORM 6-K 0001171843-24-004605 001-39307 241188166 34 15014
2024-07-26 6-K FORM 6-K 0001171843-24-004161 001-39307 241143530 34 21436
2024-07-17 6-K FORM 6-K 0001171843-24-003984 001-39307 241120960 34 15250
2024-07-02 6-K FORM 6-K 0001171843-24-003760 001-39307 241092931 34 46971
2024-06-25 144 xsl144X01/primary_doc.xml 0001959173-24-004621 001-39307 241069363 33 4991
2024-06-25 144 xsl144X01/primary_doc.xml 0001959173-24-004620 001-39307 241069284 33 5080
2024-06-03 6-K FORM 6-K 0001171843-24-003239 001-39307 241013567 34 79134
2024-05-23 6-K FORM 6-K 0001171843-24-003086 001-39307 24979377 34 78079
2024-05-13 6-K 6-K 0001801198-24-000033 001-39307 24936834 34 3935203 1 1
2024-04-22 6-K FORM 6-K 0001171843-24-002118 001-39307 24860586 34 67888
2024-04-16 6-K 6-K 0001801198-24-000030 001-39307 24846105 34 24740
2024-04-08 6-K 6-K 0001801198-24-000028 001-39307 24828156 34 124417
2024-04-05 SC 13G/A us52490g1022_040424.txt 0001086364-24-007351 005-92217 24825584 34 12784
2024-03-29 6-K 6-K 0001801198-24-000026 001-39307 24802054 34 26825
2024-03-28 144 xsl144X01/primary_doc.xml 0001950047-24-002738 001-39307 24799350 33 6012
2024-03-27 144 xsl144X01/primary_doc.xml 0001950047-24-002716 001-39307 24790812 33 5321
2024-03-26 144 xsl144X01/primary_doc.xml 0001950047-24-002707 001-39307 24784777 33 4630
2024-03-25 144 xsl144X01/primary_doc.xml 0001959173-24-002613 001-39307 24779977 33 6121
2024-03-25 144 xsl144X01/primary_doc.xml 0001959173-24-002609 001-39307 24779616 33 4239
2024-03-19 144 xsl144X01/primary_doc.xml 0001959173-24-002468 001-39307 24761486 33 4873
2024-03-19 F-3ASR F-3ASR 0001193125-24-070783 333-278050 24761123 33 1129734
2024-03-19 20-F 20-F 0001801198-24-000021 001-39307 24761065 34 29307045 1 1
2024-03-15 6-K 6-K 0001801198-24-000016 001-39307 24754278 34 104956
2024-03-13 6-K 6-K 0001801198-24-000014 001-39307 24744669 34 19086
2024-03-11 6-K 6-K 0001801198-24-000011 001-39307 24736568 34 378070
2024-02-28 144/A xsl144X01/primary_doc.xml 0001959173-24-001556 001-39307 24697883 33 7569
2024-02-28 144 xsl144X01/primary_doc.xml 0001959173-24-001550 001-39307 24697386 33 7309
2024-02-27 144 xsl144X01/primary_doc.xml 0001959173-24-001491 001-39307 24689448 33 8385
2024-02-23 144 xsl144X01/primary_doc.xml 0001959173-24-001330 001-39307 24669376 33 4966
2024-02-23 6-K 6-K 0001801198-24-000006 001-39307 24667226 34 105105
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036760 005-92217 24641661 34 35936
2024-02-14 SC 13G/A LEGEND BIOTECH CORP 0000902664-24-001736 005-92217 24639483 34 60882
2024-02-14 SC 13G legn13gdec23.txt 0000080255-24-000753 005-92217 34 6418
2024-02-09 SC 13G/A filing.txt 0000315066-24-001204 005-92217 24611742 34 8261
2024-01-29 SC 13G us52490g1022_012924.txt 0001086364-24-005610 005-92217 24574941 34 13646
2024-01-23 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-24-000092 001-39307 24550570 34 15654
2024-01-23 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-24-000091 001-39307 24550483 34 16405
2024-01-09 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-24-000040 001-39307 24523223 34 3087938
2023-12-27 144 xsl144X01/primary_doc.xml 0001959173-23-005724 001-39307 231515106 33 4817
2023-12-22 144 xsl144X01/primary_doc.xml 0001959173-23-005691 001-39307 231509586 33 6724
2023-12-22 144 xsl144X01/primary_doc.xml 0001959173-23-005690 001-39307 231509514 33 4847
2023-12-21 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-001857 001-39307 231506186 34 15026
2023-12-21 6-K 6-K 0001193125-23-301205 001-39307 231505477 34 14805
2023-12-12 144 xsl144X01/primary_doc.xml 0001959173-23-005374 001-39307 231480838 33 4224
2023-12-12 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-001819 001-39307 231479683 34 62093
2023-11-20 6-K 6-K 0001801198-23-000026 001-39307 231420627 34 5505159 1 1
2023-11-13 6-K LEGEND BIOTECH CORP. 6-K 0001157523-23-001718 001-39307 231395410 34 32355
2023-10-17 144/A xsl144X01/primary_doc.xml 0001959173-23-004364 001-39307 231330501 33 8653
2023-10-17 144 xsl144X01/primary_doc.xml 0001959173-23-004363 001-39307 231330487 33 8400
2023-10-17 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-001492 001-39307 231328466 34 16632
2023-10-16 144 xsl144X01/primary_doc.xml 0001959173-23-004340 001-39307 231328007 33 8343
2023-09-27 144 xsl144X01/primary_doc.xml 0001959173-23-004077 001-39307 231283495 33 5545
2023-09-25 6-K 6-K 0001193125-23-240933 001-39307 231273152 34 27188
2023-09-22 144 xsl144X01/primary_doc.xml 0001959173-23-004051 001-39307 231271953 33 4765
2023-09-22 144 xsl144X01/primary_doc.xml 0001959173-23-004049 001-39307 231271829 33 5445
2023-09-18 144 xsl144X01/primary_doc.xml 0001959173-23-003989 001-39307 231261629 33 7188
2023-09-15 UPLOAD filename1.pdf 0000000000-23-010246 39595
2023-09-08 CORRESP filename1.htm 0001193125-23-231191 20929
2023-08-31 UPLOAD filename1.pdf 0000000000-23-009621 46586
2023-08-28 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-001366 001-39307 231211091 34 13979
2023-08-23 144 xsl144X01/primary_doc.xml 0001959173-23-003475 001-39307 231197937 33 4234
2023-08-21 6-K 6-K 0001193125-23-216967 001-39307 231189259 34 77181
2023-08-15 6-K 6-K 0001801198-23-000023 001-39307 231173139 34 5493778 1 1
2023-07-20 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-001114 001-39307 231098108 34 17858
2023-06-26 144 xsl144X01/primary_doc.xml 0001959173-23-002087 001-39307 231040140 33 5402
2023-06-22 144 xsl144X01/primary_doc.xml 0001959173-23-002065 001-39307 231033300 33 5966
2023-06-22 144 xsl144X01/primary_doc.xml 0001959173-23-002064 001-39307 231033246 33 7254
2023-06-07 144 xsl144X01/primary_doc.xml 0001959173-23-001642 001-39307 23998507 33 6638
2023-06-06 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000941 001-39307 23996679 34 68442
2023-06-06 144 xsl144X01/primary_doc.xml 0001959173-23-001592 001-39307 23995808 33 6537
2023-06-05 144 xsl144X01/primary_doc.xml 0001959173-23-001557 001-39307 23992779 33 4793
2023-06-05 6-K LEGEND BIOTECH 6-K 0001157523-23-000938 001-39307 23991577 34 71149
2023-06-02 144 xsl144X01/primary_doc.xml 0001959173-23-001496 001-39307 23988698 33 5443
2023-06-01 144 xsl144X01/primary_doc.xml 0001959173-23-001470 001-39307 23984929 33 4836
2023-05-26 F-3ASR F-3ASR 0001193125-23-154891 333-272222 23963270 33 1232986
2023-05-25 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000909 001-39307 23956273 34 64072
2023-05-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000881 001-39307 23933772 34 382379
2023-05-16 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000855 001-39307 23925670 34 80919
2023-05-12 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000830 001-39307 23915423 34 14528
2023-05-10 SC 13G/A filing.txt 0000315066-23-002262 005-92217 23904692 34 8138
2023-05-08 6-K 6-K 0001193125-23-137735 001-39307 23895998 34 134159
2023-05-08 424B5 424B5 0001193125-23-137733 333-257609 23895995 33 742886
2023-04-28 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000026 021-480374 23866146 33 14462
2023-04-21 144 xsl144X01/primary_doc.xml 0001959173-23-000662 001-39307 23836069 33 5453
2023-04-21 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000593 001-39307 23834650 34 298434
2023-04-19 144 xsl144X01/primary_doc.xml 0001959173-23-000626 001-39307 23829148 33 5980
2023-04-19 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000577 001-39307 23828628 34 14226
2023-04-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000566 001-39307 23825567 34 16247
2023-04-14 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000551 001-39307 23819838 34 402208
2023-04-05 144 xsl144X01/primary_doc.xml 0001959173-23-000500 001-39307 23803326 33 4111
2023-04-05 144 xsl144X01/primary_doc.xml 0001959173-23-000499 001-39307 23803302 33 4139
2023-04-03 6-K LEGEND BIOTECH 6-K 0001157523-23-000509 001-39307 23792548 34 22752
2023-04-03 144 xsl144X01/primary_doc.xml 0001959173-23-000422 001-39307 23791510 33 8425
2023-03-30 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000500 001-39307 23780555 34 270716
2023-03-30 20-F 20-F 0001801198-23-000019 001-39307 23776809 34 21352600 1 1
2023-02-27 UPLOAD filename1.pdf 0000000000-23-001931 39600
2023-02-17 6-K 6-K 0001801198-23-000013 001-39307 23640277 34 69440
2023-02-17 6-K/A 6-K/A 0001801198-23-000011 001-39307 23640276 34 367773
2023-02-17 20-F/A 20-F/A 0001564590-23-002041 001-39307 23640273 34 50094991 1 1
2023-02-14 SC 13G/A LEGEND BIOTECH CORP 0000902664-23-001812 005-92217 23629338 34 61279
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039061 005-92217 23628945 34 32766
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039043 005-92217 23628711 34 51328
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039019 005-92217 23628594 34 31812
2023-02-09 SC 13G filing.txt 0000315066-23-001818 005-92217 23603080 34 8093
2023-01-27 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000110 001-39307 23559781 34 62806
2023-01-24 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000078 001-39307 23548163 34 17706
2023-01-09 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-23-000031 001-39307 23516841 34 21824
2023-01-03 6-K LEGEND BIOTECH CORP. 6-K 0001157523-23-000002 001-39307 23500041 34 53466
2022-12-08 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001713 001-39307 221451444 34 441170
2022-11-22 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001670 001-39307 221410279 34 40321
2022-11-21 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-001659 001-39307 221403558 34 22236
2022-11-04 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001534 001-39307 221362971 34 18343
2022-11-03 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001523 001-39307 221358048 34 74793
2022-10-20 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001347 001-39307 221321303 34 16412
2022-10-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001333 001-39307 221316024 34 17266
2022-10-17 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001325 001-39307 221313800 34 56093
2022-10-11 CORRESP filename1.htm 0001193125-22-260680 40886
2022-10-06 UPLOAD filename1.pdf 0000000000-22-011000 45229
2022-10-03 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001279 001-39307 221287469 34 141372
2022-09-30 CORRESP filename1.htm 0001564590-22-032968 177554
2022-09-27 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-001265 001-39307 221267487 34 61118
2022-09-16 6-K 6-K 0001564590-22-031793 001-39307 221248058 34 901322
2022-09-15 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001235 001-39307 221244532 34 18943
2022-09-02 UPLOAD filename1.pdf 0000000000-22-009595 60731
2022-08-19 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-001145 001-39307 221180732 34 18226
2022-08-05 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-001061 001-39307 221138725 34 37306
2022-08-04 6-K FORM 6-K 0001193125-22-212542 001-39307 221136868 34 154287
2022-07-27 6-K 6-K 0001193125-22-203478 001-39307 221111463 34 260090
2022-07-27 424B5 424B5 0001193125-22-203470 333-257609 221111437 33 1083427
2022-07-25 424B5 424B5 0001193125-22-200891 333-257609 221103694 33 1049399
2022-07-25 6-K FORM 6-K 0001193125-22-200851 001-39307 221103414 34 1100628
2022-07-21 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000879 001-39307 221095481 34 13606
2022-07-13 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-22-000841 001-39307 221080241 34 27175
2022-07-07 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-22-000824 001-39307 221070687 34 16330
2022-06-06 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-22-000727 001-39307 22996618 34 67703
2022-06-03 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000722 001-39307 22992964 34 27746
2022-06-02 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000717 001-39307 22990499 34 23736
2022-06-01 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000714 001-39307 22986045 34 336641
2022-05-26 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000692 001-39307 22965407 34 44174
2022-05-18 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000654 001-39307 22937126 34 74467
2022-05-09 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000586 001-39307 22903158 34 21994
2022-05-09 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000585 001-39307 22903154 34 17646
2022-05-06 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000583 001-39307 22900964 34 21898
2022-04-21 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000455 001-39307 22839748 34 22616
2022-04-13 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-22-000423 001-39307 22825481 34 14821
2022-04-01 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000387 001-39307 22798137 34 24752
2022-03-31 20-F 20-F 0001564590-22-012769 001-39307 22789198 34 32119127 1 1
2022-03-25 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000367 001-39307 22768294 34 32118
2022-03-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000354 001-39307 22752633 34 362839
2022-03-11 SC 13G/A SC 13G/A 0001193125-22-073523 005-92217 22733939 34 36438
2022-03-07 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000291 001-39307 22716117 34 14246
2022-03-01 6-K LEGEND BIOTECH CORP. 6-K 0001157523-22-000274 001-39307 22693670 34 55567
2022-02-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000221 001-39307 22650935 34 35220
2022-02-15 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000203 001-39307 22637122 34 22461
2022-02-14 SC 13G/A LEGEND BIOTECH CORP 0000902664-22-001729 005-92217 22631868 34 63170
2022-02-11 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000187 001-39307 22616899 34 22271
2022-02-02 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-22-000136 001-39307 22583551 34 11661
2022-01-04 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-22-000008 001-39307 22504166 34 18962
2021-12-30 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001530 001-39307 211530660 34 18644
2021-12-17 6-K 6-K 0001193125-21-361131 001-39307 211501820 34 350634
2021-12-17 424B5 424B5 0001193125-21-361120 333-257609 211501775 33 1257464
2021-12-16 FWP FWP 0001193125-21-358617 333-257609 211496044 34 13283
2021-12-14 424B5 424B5 0001193125-21-356850 333-257609 211491489 33 1251968
2021-12-14 6-K 6-K 0001193125-21-356822 001-39307 211491285 34 709879
2021-12-13 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001495 001-39307 211487089 34 45189
2021-12-07 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-21-001483 001-39307 211474777 34 27366
2021-12-06 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001479 001-39307 211472109 34 33271
2021-11-16 6-K LEGEND BIOTECH CORP. 6-K 0001157523-21-001420 001-39307 211414187 34 400573
2021-11-04 6-K LEGEND BIOTECH CORP. 6-K 0001157523-21-001337 001-39307 211378180 34 52775
2021-11-01 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001295 001-39307 211367084 34 28017
2021-10-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001213 001-39307 211327392 34 23473
2021-09-22 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001158 001-39307 211268220 34 16862
2021-09-13 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001135 001-39307 211248764 34 7296853
2021-08-30 6-K LEGEND BIOTECH CORPORATION FORM 6-K 0001157523-21-001102 001-39307 211221130 34 15917
2021-08-23 6-K 6-K 0001564590-21-045342 001-39307 211195416 34 10676823 1
2021-08-23 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-001084 001-39307 211195396 34 202856
2021-07-14 424B3 424B3 0001193125-21-215226 333-257625 211090295 33 368456
2021-07-13 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2021-07-13 14:00:00 9999999995-21-002741 333-257625 211089196 33 1660
2021-07-12 SC 13G LEGEND BIOTECH CORP 0000902664-21-003475 005-92217 211085677 34 41448
2021-07-09 CORRESP filename1.htm 0001193125-21-211641 5751
2021-07-08 UPLOAD filename1.pdf 0000000000-21-008394 39970
2021-07-02 F-3 F-3 0001193125-21-207037 333-257625 211067992 33 991922
2021-07-01 F-3ASR F-3ASR 0001193125-21-206350 333-257609 211066307 33 843029
2021-06-22 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000815 001-39307 211033089 34 7302208
2021-06-10 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000763 001-39307 211006932 34 41748
2021-06-09 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000756 001-39307 211004024 34 7047821
2021-06-01 6-K LEGEND BIOTECH CORP. 6-K 0001157523-21-000728 001-39307 21983102 34 34847
2021-05-27 6-K 6-K 0001193125-21-173841 001-39307 21967847 34 39241
2021-05-25 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000713 001-39307 21958362 34 13272
2021-05-20 6-K 6-K 0001193125-21-167603 001-39307 21943845 34 9901
2021-05-18 6-K 6-K 0001193125-21-164633 001-39307 21933933 34 114290
2021-05-13 6-K 6-K 0001193125-21-160541 001-39307 21920062 34 11532
2021-05-12 6-K 6-K 0001193125-21-158777 001-39307 21914621 34 52860
2021-05-05 6-K 6-K 0001193125-21-150941 001-39307 21891303 34 72465
2021-04-30 6-K 6-K 0001193125-21-142406 001-39307 21873658 34 46275
2021-04-02 20-F 20-F 0001564590-21-017439 001-39307 21800539 34 25839306 1
2021-03-18 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000358 001-39307 21753051 34 3003473
2021-03-10 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000325 001-39307 21730193 34 14946
2021-02-19 6-K LEGEND BIOTECH CORP. 6-K 0001157523-21-000225 001-39307 21652057 34 30368
2021-02-16 SC 13G SC 13G 0001193125-21-043384 005-92217 21632474 34 31121
2021-02-16 SC 13G SC 13G 0001193125-21-043372 005-92217 21632448 34 53781
2021-02-16 SC 13G SC 13G 0001193125-21-043362 005-92217 21632425 34 34327
2021-02-01 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000115 001-39307 21574333 34 26496
2021-01-11 6-K LEGEND BIOTECH CORPORATION 6-K 0001157523-21-000036 001-39307 21521167 34 5354367
2020-12-30 6-K 6-K 0001193125-20-329143 001-39307 201423999 34 37400
2020-12-21 6-K 6-K 0001193125-20-322320 001-39307 201402389 34 35338
2020-12-14 6-K 6-K 0001193125-20-317021 001-39307 201386662 34 21356
2020-12-14 6-K 6-K 0001193125-20-316434 001-39307 201385138 34 29830
2020-12-07 6-K 6-K 0001193125-20-311114 001-39307 201371284 34 48170
2020-12-03 6-K 6-K 0001193125-20-309023 001-39307 201365735 34 26391
2020-11-24 6-K 6-K 0001193125-20-302058 001-39307 201339978 34 29427
2020-11-23 6-K 6-K 0001193125-20-300418 001-39307 201334252 34 28358
2020-11-16 6-K 6-K 0001193125-20-293750 001-39307 201313631 34 200580
2020-11-09 6-K 6-K 0001193125-20-288530 001-39307 201296195 34 190020
2020-11-05 6-K 6-K 0001193125-20-286207 001-39307 201288652 34 44017
2020-09-21 6-K 6-K 0001193125-20-249677 001-39307 201185190 34 30861
2020-09-04 S-8 POS S-8 POS 0001193125-20-240097 333-239478 201162063 33 163532
2020-08-31 6-K 6-K 0001193125-20-235287 001-39307 201149701 34 130703
2020-08-06 6-K 6-K 0001193125-20-211224 001-39307 201079627 34 56723
2020-08-03 6-K 6-K 0001193125-20-207197 001-39307 201067734 34 27212
2020-08-03 6-K 6-K 0001193125-20-207190 001-39307 201067722 34 30998
2020-07-16 6-K 6-K 0001193125-20-193728 001-39307 201030775 34 11879
2020-06-26 S-8 S-8 0001193125-20-180940 333-239478 20994263 33 1028932
2020-06-08 424B4 424B4 0001193125-20-162919 333-238232 20948233 33 5281528
2020-06-04 EFFECT xslEFFECTX01/primary_doc.xml F-6,,2020-06-04 16:00:00 9999999995-20-001339 333-238581 20944402 33 1659
2020-06-04 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2020-06-04 16:00:00 9999999995-20-001333 333-238232 20944405 33 1659
2020-06-03 CERT 8A_Cert_LEGN.pdf 0001354457-20-000216 001-39307 20939323 34 90115
2020-06-02 CORRESP filename1.htm 0001193125-20-158461 20048
2020-06-02 CORRESP filename1.htm 0001193125-20-158459 14301
2020-06-02 8-A12B 8-A12B 0001193125-20-158448 001-39307 20936919 34 16162
2020-05-29 F-6/A F-6/A 0001193125-20-155321 333-238581 20925359 33 54717
2020-05-29 F-1/A F-1/A 0001193125-20-155054 333-238232 20924146 33 6669097
2020-05-21 F-6 F-6 0001193125-20-148812 333-238581 20902845 33 440561
2020-05-21 CORRESP filename1.htm 0001193125-20-148630 40993
2020-05-20 UPLOAD filename1.pdf 0000000000-20-004487 49862
2020-05-19 CORRESP filename1.htm 0001193125-20-145827 52521
2020-05-13 F-1 F-1 0001193125-20-141663 333-238232 20873727 33 6694534
2020-05-08 DRSLTR filename1.htm 0000950123-20-004168 48502
2020-05-08 DRS/A filename1.htm 0000950123-20-004167 377-03085 20859113 33 5556451
2020-05-01 UPLOAD filename1.pdf 0000000000-20-003791 51278
2020-04-20 DRSLTR filename1.htm 0000950123-20-003472 77635
2020-04-20 DRS/A filename1.htm 0000950123-20-003471 377-03085 20802146 33 4936945
2020-04-07 D xslFormDX01/primary_doc.xml 06b 0001288320-20-000003 021-364441 20778877 33 8330
2020-04-02 UPLOAD filename1.pdf 0000000000-20-002877 63469
2020-03-09 DRS filename1.htm 0000950123-20-002800 377-03085 20697037 33 4792880

Latest XBRL company facts

One latest value per concept from companyfacts (257 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 369.89M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ffd NetFeeAmt NetFeeAmt USD 15,271.02 2026-10-06 S-8 2026-10-07 0001171843-26-006498
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 259.98M 2026-06-18 424B5 2026-06-18 0001193125-26-275977
ffd TtlFeeAmt TtlFeeAmt USD 15,271.02 2026-10-06 S-8 2026-10-07 0001171843-26-006498
ffd TtlOfferingAmt TtlOfferingAmt USD 175.53M 2026-10-06 S-8 2026-10-07 0001171843-26-006498
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-06 S-8 2026-10-07 0001171843-26-006498
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-06-18 424B5 2026-06-18 0001193125-26-275977
ifrs-full AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment USD 28.82M 2021-01-01 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment USD 26.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdditionsToRightofuseAssets AdditionsToRightofuseAssets USD 195.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustedWeightedAverageShares AdjustedWeightedAverageShares shares 368.64M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForAmortisationExpense AdjustmentsForAmortisationExpense USD 228,000 2025-01-01 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full AdjustmentsForCurrentTaxOfPriorPeriod AdjustmentsForCurrentTaxOfPriorPeriod USD 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full AdjustmentsForDecreaseIncreaseInInventories AdjustmentsForDecreaseIncreaseInInventories USD -4.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForDecreaseIncreaseInOtherCurrentAssets AdjustmentsForDecreaseIncreaseInOtherCurrentAssets USD -1.18M 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAccountReceivable AdjustmentsForDecreaseIncreaseInTradeAccountReceivable USD -5.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForDepreciationExpense AdjustmentsForDepreciationExpense USD 9.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForFairValueGainsLosses AdjustmentsForFairValueGainsLosses USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForFinanceCosts AdjustmentsForFinanceCosts USD 21.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForFinanceIncome AdjustmentsForFinanceIncome USD 40.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories USD 6,000 2021-01-01 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables USD -22,000 2021-01-01 2021-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full AdjustmentsForIncreaseDecreaseInContractLiabilities AdjustmentsForIncreaseDecreaseInContractLiabilities USD -40.00M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForIncreaseDecreaseInOtherOperatingPayables AdjustmentsForIncreaseDecreaseInOtherOperatingPayables USD 36.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables USD 44.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdjustmentsForUnrealisedForeignExchangeLossesGains AdjustmentsForUnrealisedForeignExchangeLossesGains USD 168.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AdministrativeExpense AdministrativeExpense USD 135.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AllowanceAccountForCreditLossesOfFinancialAssets AllowanceAccountForCreditLossesOfFinancialAssets USD 22,000 2020-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full AmortisationIntangibleAssetsOtherThanGoodwill AmortisationIntangibleAssetsOtherThanGoodwill USD 1.93M 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full Assets Assets USD 1.73B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full AverageEffectiveTaxRate AverageEffectiveTaxRate pure -0.05 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full BasicAndDilutedEarningsLossPerShare BasicAndDilutedEarningsLossPerShare USD/shares -0.63 2021-01-01 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full BasicEarningsLossPerShare BasicEarningsLossPerShare USD/shares -0.81 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full Borrowings Borrowings USD 319.10M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full BorrowingsAdjustmentToInterestRateBasis BorrowingsAdjustmentToInterestRateBasis pure 0.025 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full BorrowingsInterestRate BorrowingsInterestRate pure 0.067 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full Cash Cash USD 948.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashAdvancesAndLoansFromRelatedParties CashAdvancesAndLoansFromRelatedParties USD 38.95M 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full CashAdvancesAndLoansMadeToRelatedParties CashAdvancesAndLoansMadeToRelatedParties USD 13.01M 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full CashAndBankBalancesAtCentralBanks CashAndBankBalancesAtCentralBanks USD 948.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashAndCashEquivalents CashAndCashEquivalents USD 901.90M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities USD -300,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities USD 709.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities USD -100.20M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashFlowsFromUsedInOperations CashFlowsFromUsedInOperations USD -138.36M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital USD -40.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashOutflowForLeases CashOutflowForLeases USD 10.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities USD 39,000 2020-01-01 2020-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties USD 63.00M 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full CashRepaymentsOfAdvancesAndLoansFromRelatedParties CashRepaymentsOfAdvancesAndLoansFromRelatedParties USD 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full ComprehensiveIncome ComprehensiveIncome USD -106.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ComprehensiveIncomeAttributableToOwnersOfParent ComprehensiveIncomeAttributableToOwnersOfParent USD -40.19M 2025-01-01 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full ConstructionInProgress ConstructionInProgress USD 23.95M 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full ContractLiabilities ContractLiabilities USD 39.53M 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full CostOfSales CostOfSales USD 397.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity USD 14.20M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentAssets CurrentAssets USD 1.25B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings USD 319.10M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentContractLiabilities CurrentContractLiabilities USD 11.30M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentDerivativeFinancialLiabilities CurrentDerivativeFinancialLiabilities USD 0 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full CurrentFinanceLeaseReceivables CurrentFinanceLeaseReceivables USD 94,000 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full CurrentFinancialAssetsAtAmortisedCost CurrentFinancialAssetsAtAmortisedCost USD 29.85M 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full CurrentFinancialAssetsAtFairValueThroughProfitOrLoss CurrentFinancialAssetsAtFairValueThroughProfitOrLoss USD 5.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentGovernmentGrants CurrentGovernmentGrants USD 651,000 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full CurrentLeaseLiabilities CurrentLeaseLiabilities USD 7.40M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentLiabilities CurrentLiabilities USD 636.40M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentPrepaymentsAndOtherCurrentAssets CurrentPrepaymentsAndOtherCurrentAssets USD 253.40M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentRawMaterialsAndCurrentProductionSupplies CurrentRawMaterialsAndCurrentProductionSupplies USD 1.75M 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full CurrentTaxLiabilities CurrentTaxLiabilities USD 19.20M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity USD 1,000 2021-01-01 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full CurrentTradeReceivables CurrentTradeReceivables USD 13.10M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities USD 52.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised USD 586.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DeferredTaxAssets DeferredTaxAssets USD 20.20M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DeferredTaxExpenseIncomeRecognisedInProfitOrLoss DeferredTaxExpenseIncomeRecognisedInProfitOrLoss USD -8.04M 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full DeferredTaxLiabilities DeferredTaxLiabilities USD 20.20M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DeferredTaxLiabilityAsset DeferredTaxLiabilityAsset USD 4.24M 2020-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DepreciationPropertyPlantAndEquipment DepreciationPropertyPlantAndEquipment USD 9.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DepreciationRightofuseAssets DepreciationRightofuseAssets USD 19.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DescriptionOfExpectedVolatilityShareOptionsGranted DescriptionOfExpectedVolatilityShareOptionsGranted pure 0.59 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DescriptionOfOptionLifeShareOptionsGranted DescriptionOfOptionLifeShareOptionsGranted year 6.09 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DilutedEarningsLossPerShare DilutedEarningsLossPerShare USD/shares -0.81 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DisposalsIntangibleAssetsOtherThanGoodwill DisposalsIntangibleAssetsOtherThanGoodwill USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full DisposalsPropertyPlantAndEquipment DisposalsPropertyPlantAndEquipment USD 1.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full DisposalsRightofuseAssets DisposalsRightofuseAssets USD 300,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents USD 6.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full EmployeeBenefitsExpense EmployeeBenefitsExpense USD 492.30M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full Equity Equity USD 1.00B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full EquityAndLiabilities EquityAndLiabilities USD 1.73B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full EquityAttributableToOwnersOfParent EquityAttributableToOwnersOfParent USD 1.02B 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full ExpectedDividendAsPercentageShareOptionsGranted ExpectedDividendAsPercentageShareOptionsGranted pure 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets USD 2.40M 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full ExpenseFromSharebasedPaymentTransactionsWithEmployees ExpenseFromSharebasedPaymentTransactionsWithEmployees USD 64.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed USD 3.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinanceCosts FinanceCosts USD 21.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinanceIncome FinanceIncome USD 40.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinanceIncomeReceivedClassifiedAsOperatingActivities FinanceIncomeReceivedClassifiedAsOperatingActivities USD 52.00M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinanceLeaseReceivables FinanceLeaseReceivables USD 285,000 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full FinancialAssetsAtAmortisedCost FinancialAssetsAtAmortisedCost USD 1.19B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinancialAssetsAtFairValue FinancialAssetsAtFairValue USD 0 2024-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinancialLiabilitiesAtAmortisedCost FinancialLiabilitiesAtAmortisedCost USD 499.80M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full FinancialLiabilitiesAtFairValueThroughProfitOrLoss FinancialLiabilitiesAtFairValueThroughProfitOrLoss USD 0 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full FinishedGoods FinishedGoods USD 6.80M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ForeignExchangeGain ForeignExchangeGain USD 109.35M 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full GainsLossesOnDisposalsOfPropertyPlantAndEquipment GainsLossesOnDisposalsOfPropertyPlantAndEquipment USD -250,000 2025-01-01 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss USD -168.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss USD 0 2025-01-01 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full GovernmentGrants GovernmentGrants USD 6.69M 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full ImpairmentLossRecognisedInProfitOrLoss ImpairmentLossRecognisedInProfitOrLoss USD 970,000 2025-01-01 2025-09-30 2025 Q3 6-K 2025-11-12 0001801198-25-000031
ifrs-full ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill USD 0 2024-01-01 2024-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipmentIncludingRightofuseAssets ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipmentIncludingRightofuseAssets USD 1.00M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ImpairmentLossRecognisedInProfitOrLossRightofuseAssets ImpairmentLossRecognisedInProfitOrLossRightofuseAssets USD 1.00M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ImpairmentLossRecognisedInProfitOrLossTradeReceivables ImpairmentLossRecognisedInProfitOrLossTradeReceivables USD 22,000 2020-01-01 2020-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full IncomeTaxesPaidClassifiedAsOperatingActivities IncomeTaxesPaidClassifiedAsOperatingActivities USD 18.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncomeTaxesPaidRefundClassifiedAsOperatingActivities IncomeTaxesPaidRefundClassifiedAsOperatingActivities USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncomeTaxExpenseContinuingOperations IncomeTaxExpenseContinuingOperations USD 14.20M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents USD 615.20M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges USD -26.00M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full IncreaseDecreaseThroughConversionOfConvertibleInstruments IncreaseDecreaseThroughConversionOfConvertibleInstruments USD 240.43M 2020-01-01 2020-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full IncreaseDecreaseThroughExerciseOfOptions IncreaseDecreaseThroughExerciseOfOptions USD 3.30M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset USD -4,000 2019-01-01 2019-12-31 2020 FY 20-F 2021-04-02 0001564590-21-017439
ifrs-full IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill USD 30,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment USD 1.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncreaseDecreaseThroughSharebasedPaymentTransactions IncreaseDecreaseThroughSharebasedPaymentTransactions USD 64.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities USD 23.70M 2022-01-01 2022-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full IntangibleAssetsOtherThanGoodwill IntangibleAssetsOtherThanGoodwill USD 1.90M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full InterestExpenseOnBorrowings InterestExpenseOnBorrowings USD 4.50M 2025-04-01 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full InterestExpenseOnDebtInstrumentsIssued InterestExpenseOnDebtInstrumentsIssued USD 24,000 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full InterestExpenseOnLeaseLiabilities InterestExpenseOnLeaseLiabilities USD 3.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full Inventories Inventories USD 32.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IssuedCapital IssuedCapital USD 100,000 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full IssueOfEquity IssueOfEquity USD 218.30M 2021-01-01 2021-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full KeyManagementPersonnelCompensation KeyManagementPersonnelCompensation USD 18.30M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full KeyManagementPersonnelCompensationSharebasedPayment KeyManagementPersonnelCompensationSharebasedPayment USD 15.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full KeyManagementPersonnelCompensationShorttermEmployeeBenefits KeyManagementPersonnelCompensationShorttermEmployeeBenefits USD 2.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full KeyManagementPersonnelCompensationTerminationBenefits KeyManagementPersonnelCompensationTerminationBenefits USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full Liabilities Liabilities USD 731.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full LongtermBorrowings LongtermBorrowings USD 0 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full LongtermDeposits LongtermDeposits USD 0 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NetAssetsLiabilities NetAssetsLiabilities USD 26.00M 2020-12-31 2020 FY 20-F 2021-04-02 0001564590-21-017439
ifrs-full NetDeferredTaxLiabilities NetDeferredTaxLiabilities USD 4.24M 2020-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full NetForeignExchangeGain NetForeignExchangeGain USD 10.14M 2023-01-01 2023-09-30 2023 Q3 6-K 2023-11-20 0001801198-23-000026
ifrs-full NoncurrentAssets NoncurrentAssets USD 486.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts USD 481.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NoncurrentContractLiabilities NoncurrentContractLiabilities USD 0 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome USD 5.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NoncurrentGovernmentGrants NoncurrentGovernmentGrants USD 6.89M 2025-06-30 2025 Q2 6-K 2025-08-11 0001801198-25-000026
ifrs-full NoncurrentLeaseLiabilities NoncurrentLeaseLiabilities USD 87.20M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NoncurrentLiabilities NoncurrentLiabilities USD 95.20M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NoncurrentPrepayments NoncurrentPrepayments USD 5.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NoncurrentRestrictedCashAndCashEquivalents NoncurrentRestrictedCashAndCashEquivalents USD 0 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NumberOfOutstandingShareOptions NumberOfOutstandingShareOptions shares 3.60M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NumberOfShareOptionsExercisableInSharebasedPaymentArrangement NumberOfShareOptionsExercisableInSharebasedPaymentArrangement shares 3.39M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NumberOfShareOptionsExercisedInSharebasedPaymentArrangement NumberOfShareOptionsExercisedInSharebasedPaymentArrangement shares 776,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement shares 82,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NumberOfShareOptionsGrantedInSharebasedPaymentArrangement NumberOfShareOptionsGrantedInSharebasedPaymentArrangement shares 15,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full NumberOfSharesIssued NumberOfSharesIssued shares 20.81M 2021-05-13 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full OtherAdjustmentsToReconcileProfitLoss OtherAdjustmentsToReconcileProfitLoss USD 1.30M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherComprehensiveIncome OtherComprehensiveIncome USD 190.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation USD 190.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax USD 60.73M 2025-01-01 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full OtherCurrentLiabilities OtherCurrentLiabilities USD 1.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherCurrentPayables OtherCurrentPayables USD 3.10M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherEmployeeExpense OtherEmployeeExpense USD 10.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherExpenseByFunction OtherExpenseByFunction USD 1.00M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherExpenseByNature OtherExpenseByNature USD 40,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full OtherFinanceIncome OtherFinanceIncome USD 601,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full OtherGainsLosses OtherGainsLosses USD -164.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherIncome OtherIncome USD 63.71M 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities USD 1.27M 2025-01-01 2025-09-30 2025 Q3 6-K 2025-11-12 0001801198-25-000031
ifrs-full OtherNoncurrentAssets OtherNoncurrentAssets USD 12.40M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherNoncurrentLiabilities OtherNoncurrentLiabilities USD 8.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherNoncurrentNonfinancialAssets OtherNoncurrentNonfinancialAssets USD 12.40M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherPayables OtherPayables USD 2.91M 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full OtherReserves OtherReserves USD 1.00B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherRevenue OtherRevenue USD 300,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome USD 7.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome pure -0.028 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ParValuePerShare ParValuePerShare USD/shares 0 2021-05-13 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities USD 3.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full PaymentsToAcquireOrRedeemEntitysShares PaymentsToAcquireOrRedeemEntitysShares USD 250,000 2020-01-01 2020-06-30 6-K 2021-08-23 0001564590-21-045342
ifrs-full Prepayments Prepayments USD 1.21M 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full ProceedsFromBorrowingsClassifiedAsFinancingActivities ProceedsFromBorrowingsClassifiedAsFinancingActivities USD 2.87M 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets USD 0 2023-01-01 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full ProceedsFromExerciseOfOptions ProceedsFromExerciseOfOptions USD 3.30M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ProceedsFromExerciseOfWarrants ProceedsFromExerciseOfWarrants USD 300.00M 2021-05-13 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full ProceedsFromIssueOfOrdinaryShares ProceedsFromIssueOfOrdinaryShares USD 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full ProceedsFromIssueOfPreferenceShares ProceedsFromIssueOfPreferenceShares USD 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full ProceedsFromSalesOrMaturityOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities ProceedsFromSalesOrMaturityOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full ProfitLoss ProfitLoss USD -296.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity USD -177.03M 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects USD -177.03M 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full ProfitLossAttributableToOwnersOfParent ProfitLossAttributableToOwnersOfParent USD -100.92M 2025-01-01 2025-03-31 2025 Q1 6-K 2025-05-13 0001801198-25-000021
ifrs-full ProfitLossBeforeTax ProfitLossBeforeTax USD -282.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities USD -136.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment USD 116.30M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full PurchaseOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities PurchaseOfFinancialAssetsMeasuredAtFairValueThroughProfitOrLossClassifiedAsInvestingActivities USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities USD 28.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full PurchasesOfGoodsRelatedPartyTransactions PurchasesOfGoodsRelatedPartyTransactions USD 14.30M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full RawMaterials RawMaterials USD 24.10M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full RecoverableAmountOfAssetOrCashgeneratingUnit RecoverableAmountOfAssetOrCashgeneratingUnit USD 5.40M 2024-12-31 2024 FY 20-F 2025-03-11 0001801198-25-000012
ifrs-full RentalIncome RentalIncome USD 13,000 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full RepaymentsOfBorrowingsClassifiedAsFinancingActivities RepaymentsOfBorrowingsClassifiedAsFinancingActivities USD 2.87M 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense USD 414.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full RetainedEarnings RetainedEarnings USD 471.20M 2021-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full Revenue Revenue USD 722.52M 2025-01-01 2025-09-30 2025 Q3 6-K 2025-11-12 0001801198-25-000031
ifrs-full RevenueFromContractsWithCustomers RevenueFromContractsWithCustomers USD 1.03B 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods USD 25.13M 2021-01-01 2021-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full RevenueFromRenderingOfServices RevenueFromRenderingOfServices USD 1.03M 2018-01-01 2018-12-31 2020 FY 20-F 2021-04-02 0001564590-21-017439
ifrs-full RevenueFromSaleOfGoods RevenueFromSaleOfGoods USD 3,000 2019-01-01 2019-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full ReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables ReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables USD 22,000 2021-01-01 2021-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full RightofuseAssets RightofuseAssets USD 285.20M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ShorttermDepositsClassifiedAsCashEquivalents ShorttermDepositsClassifiedAsCashEquivalents USD 0 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TaxEffectFromChangeInTaxRate TaxEffectFromChangeInTaxRate USD 4.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss USD 14.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TaxEffectOfForeignTaxRates TaxEffectOfForeignTaxRates USD 47.00M 2023-01-01 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full TaxExpenseIncomeAtApplicableTaxRate TaxExpenseIncomeAtApplicableTaxRate USD 46,000 2018-01-01 2018-12-31 2020 FY 20-F 2021-04-02 0001564590-21-017439
ifrs-full TaxRateEffectFromChangeInTaxRate TaxRateEffectFromChangeInTaxRate pure -0.016 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods pure 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss pure -0.05 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TaxRateEffectOfForeignTaxRates TaxRateEffectOfForeignTaxRates pure -0.09 2023-01-01 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full TaxRateEffectOfTaxLosses TaxRateEffectOfTaxLosses pure -0.057 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TradeAndOtherCurrentPayablesToRelatedParties TradeAndOtherCurrentPayablesToRelatedParties USD 1.80M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TradeAndOtherPayablesToRelatedParties TradeAndOtherPayablesToRelatedParties USD 1.80M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TradeAndOtherPayablesToTradeSuppliers TradeAndOtherPayablesToTradeSuppliers USD 83.00M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TradeAndOtherReceivablesDueFromRelatedParties TradeAndOtherReceivablesDueFromRelatedParties USD 1.70M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full TransactionPriceAllocatedToRemainingPerformanceObligations TransactionPriceAllocatedToRemainingPerformanceObligations USD 303.22M 2021-12-31 2021 FY 20-F 2022-03-31 0001564590-22-012769
ifrs-full TransfersIntoLevel3OfFairValueHierarchyAssets TransfersIntoLevel3OfFairValueHierarchyAssets USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersIntoLevel3OfFairValueHierarchyLiabilities TransfersIntoLevel3OfFairValueHierarchyLiabilities USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyAssets TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyAssets USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyLiabilities TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyLiabilities USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyAssets TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyAssets USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyLiabilities TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyLiabilities USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersOutOfLevel3OfFairValueHierarchyAssets TransfersOutOfLevel3OfFairValueHierarchyAssets USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full TransfersOutOfLevel3OfFairValueHierarchyLiabilities TransfersOutOfLevel3OfFairValueHierarchyLiabilities USD 0 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041
ifrs-full UndiscountedFinanceLeasePaymentsToBeReceived UndiscountedFinanceLeasePaymentsToBeReceived USD 1.67M 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised USD 1.55B 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full ValueAddedTaxReceivables ValueAddedTaxReceivables USD 0 2022-12-31 2022 FY 20-F 2023-03-30 0001801198-23-000019
ifrs-full WagesAndSalaries WagesAndSalaries USD 417.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WarrantLiability WarrantLiability USD 0 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 USD/shares 11.148 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 USD/shares 4.515 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 USD/shares 18.285 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 USD/shares 19.04 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019 WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019 USD/shares 17.305 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 USD/shares 11.769 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WeightedAverageFairValueAtMeasurementDateShareOptionsGranted WeightedAverageFairValueAtMeasurementDateShareOptionsGranted USD 4.80M 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full WeightedAverageSharePriceShareOptionsGranted2019 WeightedAverageSharePriceShareOptionsGranted2019 USD/shares 13.397 2023-01-01 2023-12-31 2023 FY 20-F 2024-03-19 0001801198-24-000021
ifrs-full WeightedAverageShares WeightedAverageShares shares 368.64M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
ifrs-full WorkInProgress WorkInProgress USD 1.10M 2025-12-31 2025 FY 20-F 2026-03-10 0001801198-26-000008
us-gaap OtherIncome Other Income USD 2.74M 2021-01-01 2021-12-31 2021 FY 20-F/A 2023-02-17 0001564590-23-002041

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →